SMELLS LIKE CRSwNP: CONTROLLING TYPE 2 INFLAMMATION AND IMPROVING SENSE OF SMELL IN CRSwNP

12:50–14:20  EEST

Program Description
Olfactory dysfunction is a prevalent symptom of severe CRSwNP that can significantly impair physical and psychological health. During this symposium, experts will discuss the mechanisms underlying olfactory dysfunction in severe CRSwNP and share evidence that dupilumab—a monoclonal antibody and dual inhibitor of IL-4 and IL-13 signaling—reduces symptom burden and improves key outcomes in patients with CRSwNP.  This expert panel will share their experiences, clinical data, and considerations to inform patient management and the important role of smell in treatment decisions.

Faculty

Joaquim Mullol, MD, PhD (Chair)
Professor of Research
Director, Rhinology Unit and Smell Clinic
ENT Department, Hospital Clinic Barcelona
University of Barcelona
Head, Clinical and Experimental Respiratory Allergy, IDIBAPS
Barcelona, Catalonia, Spain

Martin Desrosiers, MD, FRCSC
Sinus Surgeon
University of Montreal Hospital Centre
Clinical Professor
University of Montreal
Montreal, Quebec, Canada

Martin Wagenmann, MD
Head, Rhinology, Allergy, and Endoscopic Skull Base Surgery
Department of Otorhinolaryngology
Vice-Chair, Interdisciplinary University Allergy Centre
Head, Research Laboratory of the ENT Department
University Hospital of Düsseldorf
Düsseldorf, Germany